- $6.47m
- $4.43m
- $3.55m
- 69
- 87
- 28
- 66
Annual income statement for BAB, fiscal year end - November 30th, USD millions except per share, conversion factor applied.
2020 November 30th | 2021 November 30th | 2022 November 30th | 2023 November 30th | 2024 November 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2.37 | 3.07 | 3.29 | 3.51 | 3.55 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2.14 | 2.3 | 2.68 | 2.9 | 2.88 |
| Operating Profit | 0.233 | 0.77 | 0.608 | 0.615 | 0.665 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 0.234 | 0.77 | 0.608 | 0.65 | 0.731 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.066 | 0.651 | 0.432 | 0.467 | 0.525 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.066 | 0.651 | 0.432 | 0.467 | 0.525 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.066 | 0.651 | 0.432 | 0.467 | 0.525 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.009 | 0.063 | 0.059 | 0.064 | 0.073 |
| Dividends per Share | |||||
| Special Dividends per Share |